Label: DRAMAMINE- dimenhydrinate tablet

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: OTC monograph final

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated April 14, 2022

If you are a consumer or patient please visit this version.

  • SPL UNCLASSIFIED SECTION

    Drug Facts

  • Active ingredient (in each tablet)

    Dimenhydrinate 50 mg

  • Purpose

    Antiemetic

  • Use

    for prevention and treatment of these symptoms associated with motion sickness:

    • nausea
    • vomiting
    • dizziness
  • Warnings

    Do not give to children under 2 years of age unless directed by a doctor

    Ask a doctor before use if you have

    • a breathing problem such as emphysema or chronic bronchitis
    • glaucoma
    • trouble urinating due to an enlarged prostate gland

    Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers

    When using this product

    • marked drowsiness may occur
    • avoid alcoholic drinks
    • alcohol, sedatives, and tranquilizers may increase drowsiness
    • be careful when driving a motor vehicle or operating machinery

    If pregnant or breast-feeding, ask a doctor before use.

    Keep out of reach of children.

    In case of accidental overdose, get medical help or contact a Poison Control Center (1-800-222-1222) immediately.

  • Directions

    • to prevent motion sickness, the first dose should be taken 1/2 to 1 hour before starting activity
    • to prevent or treat motion sickness, see below:
    adults and children 12 years and over
    • take 1 to 2 chewable tablets every 4-6 hours
    • do not take more than 8 chewable tablets in 24 hours, or as directed by a doctor
    children 6 to under 12 years
    • give 1/2 to 1 chewable tablet every 6-8 hours
    • do not give more than 3 chewable tablets in 24 hours, or as directed by a doctor
    children 2 to under 6 years
    • give 1/2 chewable tablet every 6-8 hours
    • do not give more than 1½ chewable tablets in 24 hours, or as directed by a doctor
  • Other information

    • Phenylketonurics: contains phenylaline 0.84 mg per tablet
    • store at room tempurature 20°- 25°C (68°-77°F)
    • do not use if pouch is opened
    • see bottom of this panel for lot number and expiration date
  • Inactive ingredients

    anhydrous citric acid, aspartame, FD&C yellow #6 aluminum lake, flavors, magnesium stearate, maltodextrin, methacrylic acid copolymer, modified starch, sorbitol

  • Questions or comments?

    call 1-800-382-7219

  • SPL UNCLASSIFIED SECTION

    Dist By:
    Medtech Products, Inc. Tarrytown, NY 10591

    Product Repackaged and Distributed
    with permission of manufacturer by:
    Select Corporation Carrollton, TX 75007

  • PRINCIPAL DISPLAY PANEL - 50 mg Tablet Packet Carton

    #1
    Pharmacist
    Recommended
    BRAND

    DIMENHYDRINATE
    TABLETS / ANTIEMETIC

    Dramamine®

    motion sickness

    CHEWABLE

    Dual Action:

    Prevents & Relieves Nausea,
    Dizziness and Vomiting

    TO OPEN
    PUSH IN TAB AND PULL OUT

    25 Packets of 2 Orange Flavor Tablets
    (50 mg each)

    PRINCIPAL DISPLAY PANEL - 50 mg Tablet Packet Carton
  • INGREDIENTS AND APPEARANCE
    DRAMAMINE 
    dimenhydrinate tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:52904-962(NDC:63029-901)
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    DIMENHYDRINATE (UNII: JB937PER5C) (chlortheophylline - UNII:GE2UA340FM) DIMENHYDRINATE50 mg
    Inactive Ingredients
    Ingredient NameStrength
    silicon dioxide (UNII: ETJ7Z6XBU4)  
    croscarmellose sodium (UNII: M28OL1HH48)  
    lactose, unspecified form (UNII: J2B2A4N98G)  
    magnesium stearate (UNII: 70097M6I30)  
    MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
    Product Characteristics
    ColorORANGEScore2 pieces
    ShapeROUNDSize8mm
    FlavorORANGEImprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:52904-962-041 in 1 BLISTER PACK01/15/2012
    12 in 1 POUCH; Type 0: Not a Combination Product
    2NDC:52904-962-2525 in 1 CARTON01/15/2012
    22 in 1 POUCH; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph finalpart33601/15/2012
    Labeler - Select Corporation (053805599)